Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127131322 | 12713132 | 2 | F | 2016 | 20160901 | 20160902 | 20160907 | PER | US-PFIZER INC-2016409644 | PFIZER | 61.00 | YR | F | Y | 90.72000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127131322 | 12713132 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 3X/DAY | U | 21446 | 75 | MG | CAPSULE, HARD | TID | |||||
| 127131322 | 12713132 | 2 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 3X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||||
| 127131322 | 12713132 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 2 DF, 2X/DAY (TWO TABLETS TWICE DAILY) | U | 21446 | 2 | DF | CAPSULE, HARD | BID | |||||
| 127131322 | 12713132 | 4 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 127131322 | 12713132 | 5 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 3X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||||
| 127131322 | 12713132 | 6 | SS | LYRICA | PREGABALIN | 1 | 200 MG, 3X/DAY | U | 21446 | 200 | MG | CAPSULE, HARD | TID | ||||||
| 127131322 | 12713132 | 7 | SS | LYRICA | PREGABALIN | 1 | 200 MG, 2X/DAY | U | 21446 | 200 | MG | CAPSULE, HARD | BID | ||||||
| 127131322 | 12713132 | 8 | SS | LYRICA | PREGABALIN | 1 | 450 MG, UNK | U | 21446 | 450 | MG | CAPSULE, HARD | |||||||
| 127131322 | 12713132 | 9 | SS | PERSANTINE | DIPYRIDAMOLE | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | ||||||
| 127131322 | 12713132 | 10 | SS | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 127131322 | 12713132 | 11 | SS | TURMERIC | TURMERIC | 1 | Oral | 1200 MG, 2X/DAY | Y | 0 | 1200 | MG | CAPSULE | BID | |||||
| 127131322 | 12713132 | 12 | C | HCD/APAP | 2 | Oral | UNK (40MG HYDROCODONE/200MG ACETAMINOPHEN, ONE EVERY 8 HOURS) | 0 | PROLONGED-RELEASE CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127131322 | 12713132 | 1 | Neuropathy peripheral |
| 127131322 | 12713132 | 9 | Anticoagulant therapy |
| 127131322 | 12713132 | 10 | Blood potassium decreased |
| 127131322 | 12713132 | 11 | Pain |
| 127131322 | 12713132 | 12 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127131322 | 12713132 | Drug ineffective | |
| 127131322 | 12713132 | Drug intolerance | |
| 127131322 | 12713132 | Drug screen false positive | |
| 127131322 | 12713132 | Incoherent | |
| 127131322 | 12713132 | Somnolence | |
| 127131322 | 12713132 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127131322 | 12713132 | 1 | 201601 | 0 | ||
| 127131322 | 12713132 | 3 | 20160212 | 0 | ||
| 127131322 | 12713132 | 4 | 201604 | 0 | ||
| 127131322 | 12713132 | 5 | 20160614 | 0 | ||
| 127131322 | 12713132 | 6 | 20160817 | 20160826 | 0 | |
| 127131322 | 12713132 | 7 | 20160826 | 0 | ||
| 127131322 | 12713132 | 9 | 2010 | 0 | ||
| 127131322 | 12713132 | 10 | 201509 | 0 | ||
| 127131322 | 12713132 | 11 | 201602 | 20160812 | 0 | |
| 127131322 | 12713132 | 12 | 20160817 | 0 |